Inflammatory Bowel Disease (IBD) Treatment Market to expand at a ~6% CAGR during 2019 - 2022

IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Segmentation by Drug Class: TNF Inhibitors, Aminosalicylates, Integrin Antagonists, and Corticosteroids; Disease Indication: Ulcerative Colitis and Crohn’s Disease; Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies, and Forecast, 2019 - 2027

Š2019 Transparency Market Research, All Rights Reserved

Sr. No.

Content

Chapter 1

Preface

Chapter 2

Assumptions and Research Methodology

Chapter 3

Market Overview

Chapter 4

Market Dynamics

Chapter 5

Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Analysis and Forecasts, By Software Type

Chapter 6

Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Analysis, by Modality

Chapter 7

Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Analysis, by Application

Chapter 8

Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Analysis, by End-user

Chapter 9

Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Analysis and Forecast by Region

Chapter 10

Europe IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Analysis and Forecast

Chapter 11

Asia Pacific IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Analysis and Forecast

Chapter 12

Latin America IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Analysis and Forecast

Chapter 13

Middle East & Africa IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Analysis and Forecast

Chapter 14

Competition Landscape

Š2019 Transparency Market Research, All Rights Reserved



Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract.



Inflammatory bowel disease is an umbrella term that comprises two principal disorders: ulcerative colitis and Crohn’s disease.



Ulcerative colitis is a long-term medical indication that causes inflammation and sores in the inner lining of the colon and rectum.



Crohn’s disease is part of inflammatory bowel disease that causes inflammation to any part of the gastrointestinal tract, right from mouth to small intestine and anus.

©2019 Transparency Market Research, All Rights Reserved



The global IBD (ulcerative colitis and Crohn’s disease) treatment market is projected to expand at a ~6% CAGR during the forecast period.



Growth of the global IBD treatment market can be attributed to rise in the prevalence of inflammatory bowel diseases across the world, development of novel drugs, novel pipeline drugs, and increase in access to the treatment of IBD.



The availability and launch of biosimilar drugs for the treatment of IBD and rise in the adoption of biologic drugs are the other factors fueling the growth of the global IBD treatment market.



Rise in investments in building a robust pipeline for IBD and increase in lifestylerelated risk factors are likely to boost the growth of the global IBD treatment market.

©2019 Transparency Market Research, All Rights Reserved



The exact cause of inflammatory bowel disease is not known; however, researchers consider the combination of several factors such as autoimmune diseases, genetic factors, unhealthy lifestyles, smoking, and environment that lead to the development of symptoms of inflammatory bowel disease.



The global IBD (ulcerative colitis and Crohn’s disease) treatment market is consolidated in terms of number of players.



A small number of players account for a majority share of the global market.



Key players operating in the global IBD treatment market include Valeant Pharmaceuticals International, Inc., Allergan plc, Pfizer, Inc., Janssen Biotech, Inc. (Johnson & Johnson), Takeda Pharmaceutical Company Limited., AbbVie, Inc., Novartis AG, UCB, Inc., and Biogen, Inc.

©2019 Transparency Market Research, All Rights Reserved

To know more about us, please visit our website www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com

Thank You

Š2019 Transparency Market Research, All Rights Reserved